» Articles » PMID: 38069673

Structural and Functional Damage to Neuronal Nuclei Caused by Extracellular Tau Oligomers

Abstract

Introduction: Neuronal nuclei are normally smoothly surfaced. In Alzheimer's disease (AD) and other tauopathies, though, they often develop invaginations. We investigated mechanisms and functional consequences of neuronal nuclear invagination in tauopathies.

Methods: Nuclear invagination was assayed by immunofluorescence in the brain, and in cultured neurons before and after extracellular tau oligomer (xcTauO) exposure. Nucleocytoplasmic transport was assayed in cultured neurons. Gene expression was investigated using nanoString nCounter technology and quantitative reverse transcription polymerase chain reaction.

Results: Invaginated nuclei were twice as abundant in human AD as in cognitively normal adults, and were increased in mouse neurodegeneration models. In cultured neurons, nuclear invagination was induced by xcTauOs by an intracellular tau-dependent mechanism. xcTauOs impaired nucleocytoplasmic transport, increased histone H3 trimethylation at lysine 9, and altered gene expression, especially by increasing tau mRNA.

Discussion: xcTauOs may be a primary cause of nuclear invagination in vivo, and by extension, impair nucleocytoplasmic transport and induce pathogenic gene expression changes.

Highlights: Extracellular tau oligomers (xcTauOs) cause neuronal nuclei to invaginate. xcTauOs alter nucleocytoplasmic transport, chromatin structure, and gene expression. The most upregulated gene is MAPT, which encodes tau. xcTauOs may thus drive a positive feedback loop for production of toxic tau.

Citing Articles

Calcineurin inhibition prevents synaptic plasticity deficit induced by brain-derived tau oligomers.

Scaduto P, Marcatti M, Bhatt N, Kayed R, Taglialatela G Brain Commun. 2024; 6(5):fcae277.

PMID: 39239152 PMC: 11375858. DOI: 10.1093/braincomms/fcae277.


Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies.

Zhang X, Wang J, Zhang Z, Ye K Transl Neurodegener. 2024; 13(1):40.

PMID: 39107835 PMC: 11302116. DOI: 10.1186/s40035-024-00429-6.


Cell redistribution of G quadruplex-structured DNA is associated with morphological changes of nuclei and nucleoli in neurons during tau pathology progression.

Comptdaer T, Tardivel M, Schirmer C, Buee L, Galas M Brain Pathol. 2024; 35(2):e13262.

PMID: 38649330 PMC: 11835446. DOI: 10.1111/bpa.13262.


Structural and functional damage to neuronal nuclei caused by extracellular tau oligomers.

Sun X, Eastman G, Shi Y, Saibaba S, Oliveira A, Lukens J Alzheimers Dement. 2023; 20(3):1656-1670.

PMID: 38069673 PMC: 10947977. DOI: 10.1002/alz.13535.

References
1.
Frost B, Jacks R, Diamond M . Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem. 2009; 284(19):12845-52. PMC: 2676015. DOI: 10.1074/jbc.M808759200. View

2.
Wang Y, Balaji V, Kaniyappan S, Kruger L, Irsen S, Tepper K . The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener. 2017; 12(1):5. PMC: 5237256. DOI: 10.1186/s13024-016-0143-y. View

3.
Liu G, Qu J, Suzuki K, Nivet E, Li M, Montserrat N . Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. Nature. 2012; 491(7425):603-7. PMC: 3504651. DOI: 10.1038/nature11557. View

4.
Goedert M, Clavaguera F, Tolnay M . The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci. 2010; 33(7):317-25. DOI: 10.1016/j.tins.2010.04.003. View

5.
Underwood R, Gannon M, Pathak A, Kapa N, Chandra S, Klop A . 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model. Acta Neuropathol Commun. 2021; 9(1):13. PMC: 7792107. DOI: 10.1186/s40478-020-01110-5. View